Log in to save to my catalogue

Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular...

Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1962604274

Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods

About this item

Full title

Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods

Publisher

United States: Public Library of Science

Journal title

PloS one, 2017-11, Vol.12 (11), p.e0187755

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

To evaluate the potential value of using a serological assay to quantitate the hepatitis C virus core antigen (HCV-Ag) when monitoring patients with chronic hepatitis C being treated with direct-acting antivirals (DAAs).
Ninety-six patients treated with DAAs, either alone (91) or in combination with PEG interferon (5), were tested for HCV-RNA an...

Alternative Titles

Full title

Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1962604274

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1962604274

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0187755

How to access this item